Don’t have an account? Sign up with Email

FDA sees benefits of linking universal device IDs to EHRs

The Food and Drug Administration contends that universal device identifiers will enable the agency to actively monitor medical device performance and better identify patient safety concerns and recalls.


Amy Abernethy, chief medical officer and senior vice president of oncology at Flatiron Health Inc., speaks during a Bloomberg Live panel discussion in Washington, D.C., U.S., on Tuesday, Sept. 19, 2017. The event is titled The Future of Health Care: Unlocking & Supporting Value. Photographer: Andrew Harrer/Bloomberg

More for you

See All
Loading data for hdm_tax_topic #better-outcomes...